$221.42
+ $3.91 (1.80%)
End-of-day quote: 05/06/2024
NasdaqGS:BIIB

Biogen Annual Report

Year Year 2023 2022 2021 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Rev. Revenue
$9.84B $10.17B $10.98B $2.21B $2.42B $2.68B $3.17B $4.10B $4.38B $4.72B $5.04B $5.51B $6.93B $9.70B $10.76B $11.45B $12.27B $13.45B $14.38B $13.44B
GM % Gross Margin %
74.24% 77.61% 80.79% 74.94% 84.58% 89.77% 89.43% 90.19% 91.27% 91.66% 90.73% 90.11% 87.63% 87.93% 88.48% 87.48% 86.72% 86.50% 86.40% 86.57%
OM Operating Margin
19.14% 29.63% 31.24% 1.96% 15.92% 27.98% 27.23% 30.00% 29.59% 33.41% 35.11% 33.34% 35.92% 40.89% 46.59% 49.86% 47.96% 47.31% 50.63% 34.63%
EPS Earnings Per Share
$0.00 $14.72 $17.67 $19.22 $33.70 $33.57 $26.20 $21.81 $20.22 $17.01 $13.83 $8.96 $6.53 $5.90 $5.15 $4.12 $3.66 $2.74 $2.25 $1.57 $1.44
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Sha. Shares
144.9m 144.1m 147m 336.7m 339.96m 338.17m 295.7m 288.05m 274.86m 240.54m 242.12m 236.58m 236.33m 234.6m 218.6m 215.9m 211.5m 197.2m 174.2m 152.4m
OCF Operating Cash Flow
$1.55B $1.38B $3.64B $727.99M $889.50M $841.27M $1.02B $1.56B $1.07B $1.62B $1.73B $1.88B $2.35B $2.94B $3.92B $4.59B $4.55B $6.19B $7.08B $4.23B
FCF Free Cash Flow
$2.05B $1.14B $3.38B $366.98M $571.12M $642.96M $734.64M $1.29B $909.25M $1.45B $1.52B $1.63B $2.10B $2.65B $3.07B $3.91B $3.68B $5.42B $6.56B $3.81B
FCFS Free Cash Flow Per Share
$8.54 $7.85 $22.43 $1.07 $1.70 $1.90 $2.33 $4.40 $3.16 $5.75 $6.27 $6.83 $-4.91 $11.11 $14.14 $17.67 $12.17 $25.87 $34.25 $22.86